IGGi-11me
Product Specifications
Bioactivity
IGGi-11me, a prodrug that can permeate membranes, is derived from IGGi-11, the inaugural inhibitor targeting the noncanonical activation of heterotrimeric G-protein signaling. By binding to G-protein ?-subunits (G?i), IGGi-11 specifically disrupts their interaction with GIV/Girdin, thereby obstructing noncanonical G-protein signaling in tumor cells and hindering the proinvasive characteristics of metastatic cancer cells.
Molecular Formula
C25H32N2O8S2
Molecular Weight
552.66
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1100019-01 0.02 mg (E-Coli)
Recombinant Sinorhizobium medicae 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD)
Ask
View Details MBS1100019-02 0.02 mg (Yeast)
Recombinant Sinorhizobium medicae 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD)
Ask
View Details MBS1100019-03 0.1 mg (E-Coli)
Recombinant Sinorhizobium medicae 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD)
Ask
View Details 
MBS1100019-04 0.1 mg (Yeast)
Recombinant Sinorhizobium medicae 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD)
Ask
View Details MBS1100019-05 0.02 mg (Baculovirus)
Recombinant Sinorhizobium medicae 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD)
Ask
View Details MBS1100019-06 0.02 mg (Mammalian-Cell)
Recombinant Sinorhizobium medicae 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD)
Ask
View Details